Autopsy report · NCT01168908

Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy

“As recommended by the DSMB.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 3 years 4 months before it stopped.
• 20 participants enrolled.
• Results were posted on the registry 4 years 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Sponsor type

University, hospital or other

Conditions

Duchenne Muscular Dystrophy; Becker Muscular Dystrophy

Interventions

Sildenafil

Participants

20

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.